We are a health technology company that offers DNA screening for men, women, and their children. Our philosophy is simple: focus on diseases where advanced knowledge makes a difference in health outcomes.
Our team consists of top-tier engineers, scientists, and healthcare professionals who work together to provide people with meaningful health data.
We integrate sophisticated technology with custom automation in our CLIA-approved, CAP-accredited and NYS CLEP-certified medical laboratory.
Counsyl has worked with thousands of providers to screen over half a million patients. The Counsyl platform extends beyond family preparation to include pregnancy screening and inherited cancer screening.
Led by co-founders Ramji Srinivasan, CEO; Eric Evans, Chief Scientist; and Rishi Kacker, VP of Engineering, Counsyl has raised a total of $102M and is privately funded by Founders Fund, Pilot Growth Equity, Goldman Sachs Asset Management, Felicis Ventures, and other prominent investors.